Samuel Reich

Samuel Reich

Chief Executive Officer at SAB BIOTHERAPEUTICS, INC.

Net worth: 78 840 $ as of 2026-05-30

51 year
Health Technology
Commercial Services
Consumer Services

Profile

Samuel J.
Reich
was the founder of Acuity Pharmaceuticals, Inc., founded in 2002, where the title held was Vice President-Research & Development from 2002 to 2007.
Mr. Reich is the founder of Biscayne Pharmaceuticals, Inc., founded in 2011, holding the title of President & Director.
Mr. Reich is the founder of Biscayne Neurotherapeutics, Inc., founded in 2011, with the title of Executive Chairman & President from 2011 to 2018.
Current jobs include Chief Executive Officer & Director at SAB Biotherapeutics, Inc. starting in 2021, and Executive Chairman at SAB Sciences, Inc. Former jobs include Director, Chief Executive & Financial Officer at Big Cypress Acquisition Corp.
from 2020 to 2021, Executive Vice President at eXegenics, Inc. in 2007, and Executive Vice President-Ophthalmologics at OPKO Health, Inc. from 2007 to 2008.
Education includes undergraduate studies at Clark University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-01 21,900 ( 0.05% ) 78 840 $ 2026-05-30

Samuel Reich active positions

CompaniesPositionStart
SAB BIOTHERAPEUTICS, INC. Chief Executive Officer 2024-02-01
Chairman -

Former positions of Samuel Reich

CompaniesPositionEnd
BIG CYPR Chief Executive Officer 2021-10-21
Founder 2018-09-30
Founder 2018-09-30
OPKO HEALTH, INC. Corporate Officer/Principal 2008-10-31
Corporate Officer/Principal 2007-06-12
See the detail of Samuel Reich's experience

Training of Samuel Reich

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

29

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Services

Health Technology

Health Technology

Finance

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!